Clinical Trial Update: Safety & Effectiveness Study of the Hydrus Microstent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery (HORIZON) [NA]

View source ↗

Summary

A completed safety and effectiveness trial evaluating the Hydrus Microstent for lowering intraocular pressure in glaucoma patients undergoing cataract surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Hydrus Microstent

Snippet

Sponsor: Ivantis, Inc. | Conditions: Primary Open Angle Glaucoma | NA | Status: COMPLETED | Results posted: 2019-09-06